世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界的な出生数の増加に伴い、新生児スクリーニングの普及率が高まり、新生児メタボリックスクリーニングの全体的な市場を促進する


With global rising birth, the rising prevalence of new born screening propels the overall market for new-born metabolic screening

新生児メタボリックスクリーニングの世界市場。報告書の範囲 Persistence Market Research社の最新刊「新生児代謝スクリーニングの世界市場」は、機会や現在の市場展望を評価し、詳細な分析、市場に影響を与え... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Persistence Market Research
パーシスタンスマーケットリサーチ
2022年12月19日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
288 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

新生児メタボリックスクリーニングの世界市場。報告書の範囲

Persistence Market Research社の最新刊「新生児代謝スクリーニングの世界市場」は、機会や現在の市場展望を評価し、詳細な分析、市場に影響を与える対応セクションに関する最新情報を提供しています。この調査は、市場の促進要因、抑制要因、動向、機会などを含む現在の市場力学に関する詳細な洞察を提供します。市場調査の主な目的は、市場が2022年から2032年の予測期間中にどのように実行されるかという排他的な情報を提示することです。

市場の成功成長のための重要な指標は、この包括的なレポートで提示されており、市場の前年比(YoY)成長分析、複合年間成長率(CAGR)など、Persistence Market Research社の調査において網羅的に記述されています。この調査研究は、世界の新生児メタボリックスクリーニングサービスの需要と調査期間中の定量的な発展機会を知るために読者をサポートすることができます。

この調査は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなどの景観の株主にとって有益であり、世界の新生児代謝スクリーニング市場で繁栄するための適切なビジネス戦略の開発に役立てることができます。このPersistence Market Researchの調査で示された洞察と情報は、新生児代謝スクリーニング市場の株主、業界専門家、投資家、研究者、記者、ビジネス愛好家が活用することができる。

市場統計、および新生児代謝スクリーニング市場のビジネスシナリオに影響を与えるマクロおよびミクロ経済変数に関連する情報も、現在の研究に含まれています。市場の潜在的な発展に応じて、実質的な洞察も本レポートで遭遇します。さらに、このレポートで提出されたデータによって、業界のマイナーな企業や新規参入者は、市場での牽引力を達成するために適切な会社の選択を行う際に支援されることができます。

主要な市場セグメント

Persistence Market Research社の調査による、世界の新生児メタボリックスクリーニング市場は、テスト、サンプル、エンドユーザー、地域という4つの重要なセグメントに分けて情報を提供しています。本レポートは、これらのカテゴリに関連する重要な市場力学と成長パラメータに関する包括的なデータおよび情報を提供します。

検査

ガラクトース血症
鎌状赤血球症
嚢胞性線維症
トキソプラズマ症
フェニルケトン尿症(PKU)
メチルマロン酸血症
メイプルシロップ尿症(MSUD)
チロシン血症
シトルリン血症
中鎖アシルCoAデヒドロゲナーゼ(MCAD)欠乏症
サンプル

血液
尿
エンドユーザー

診断ラボラトリー
専門クリニック
病院
地域別

北アメリカ
ラテンアメリカ
ヨーロッパ
南アジア
東アジア
オセアニア
中東・アフリカ
報告書に記載されている主な質問

今後数年間、新生児メタボリックスクリーニングで最も収益性の高い市場を維持し続けるのはどの地域か?
トレンドの変化は市場にどのような影響を与えるか?
COVID-19危機は市場の成長にどのような影響を与えたか?
市場参加者はどのようにして先進地域の低空飛行の機会を捕らえることができるのか?
市場におけるステークホルダーの戦略はどのようなものですか?
投資家が認識する必要があり、市場への投資中に取り組む可能性がある抑制要因は何か?
市場に影響を与える開発トレンドは何か?
新生児メタボリックスクリーニング市場の企業は、どのようにして先進国および新興国の成長機会を利用することができますか?
調査方法

Persistence Market Research社の調査では、新生児代謝スクリーニング市場の成長に関する広範な調査を実施し、市場の将来の成長パラメータに関する結論に到達するために、独自の調査手法を利用しています。この調査方法は、一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立ちます。

市場調査作成時にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは一次資料として、本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行いました。

一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、新生児代謝スクリーニング市場の成長見通しに関するPersistence Market Researchの予測はより正確で信頼できるものとなっています。

ページTOPに戻る


目次

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Development/Innovation Trends

4. Key Success Factors

    4.1. Service Adoption / Usage Analysis

    4.2. New Product Launches

    4.3. Value chain Analysis

    4.4. PESTEL Analysis

    4.5. Porter’s Analysis

    4.6. Key Promotional Strategies, By Key Manufacturers

    4.7. Regulatory Landscape

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure

        5.1.3. Global Metabolic Screening Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increasing End User Facilities

        5.2.2. New-Born Metabolic Screening Penetration Rate

        5.2.3. Key Players Historical Growth

        5.2.4. Newborn Metabolic Screening Adoption Across Regions

        5.2.5. New-Born Metabolic Screening Test Cost

        5.2.6. Technological Advancements

        5.2.7. Regulatory Impositions

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis – Impact Assessment

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Test

        6.1.2. By Sample

        6.1.3. By End User

        6.1.4. By Region

    6.2. 2022 Market Scenario

7. Global New-Born Metabolic Screening Market Demand Volume (Units) Analysis 2015–2022 and Forecast, 2023–2033

    7.1. Historical Market Volume (Units) Analysis, 2015–2022

    7.2. Current and Future Market Volume (Units) Projections, 2023–2033

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global New-Born Metabolic Screening Market Demand Pricing Analysis 2015–2022 and Forecast, 2023–2033

    8.1. Regional Pricing Analysis

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

9. Global New-Born Metabolic Screening Market Demand Value or Size (US$ Mn) Analysis 2015 – 2022 and Forecast, 2023–2033

    9.1. Historical Market Value (US$ Mn) Analysis, 2015 – 2022

    9.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global New-Born Metabolic Screening Market Analysis 2015– 2022 and Forecast 2023–2033, By Test

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test, 2015 – 2022

    10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Test, 2023–2033

        10.3.1. Galactosemia

        10.3.2. Sickle Cell Disease

        10.3.3. Cystic Fibrosis

        10.3.4. Toxoplasmosis

        10.3.5. Phenylketonuria (PKU)

        10.3.6. Methylmalonic Acidemia

        10.3.7. Maple Syrup Urine Disease (MSUD)

        10.3.8. Tyrosinemia

        10.3.9. Citrullinemia

        10.3.10. Medium Chain Acyl CoA Dehydrogenase (MCAD) Deficiency

    10.4. Market Attractiveness Analysis By Test

11. Global New-Born Metabolic Screening Market Analysis 2015– 2022 and Forecast 2023–2033, By Sample

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) By Sample, 2015 – 2022

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample, 2023–2033

        11.3.1. Blood

        11.3.2. Urine

    11.4. Market Attractiveness Analysis By Sample

12. Global New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033, By End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) By End User, 2015 – 2022

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033

        12.3.1. Diagnostic Laboratories

        12.3.2. Specialty Clinics

        12.3.3. Hospitals

    12.4. Market Attractiveness Analysis By End User

13. Global New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033, By Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Region, 2015 – 2022

    13.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Region, 2023–2033

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. South Asia

        13.3.5. East Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Trend Analysis by Market Taxonomy, 2015 – 2022

    14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        14.3.1. By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Test

        14.3.3. By Sample

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Test

        14.4.3. By Sample

        14.4.4. By End User

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. U.S. New-Born Metabolic Screening Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Test

                14.8.1.2.2. By Sample

                14.8.1.2.3. By End User

        14.8.2. Canada New-Born Metabolic Screening Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Test

                14.8.2.2.2. By Sample

                14.8.2.2.3. By End User

15. Latin America New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        15.3.1.  By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Test

        15.3.3. By Sample

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Test

        15.4.3. By Sample

        15.4.4. By End User

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. Brazil New-Born Metabolic Screening Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Test

                15.8.1.2.2. By Sample

                15.8.1.2.3. By End User

        15.8.2. Mexico New-Born Metabolic Screening Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Test

                15.8.2.2.2. By Sample

                15.8.2.2.3. By End User

        15.8.3. Argentina New-Born Metabolic Screening Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Test

                15.8.3.2.2. By Sample

                15.8.3.2.3. By End User

16. Europe New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

        16.3.2. By Test

        16.3.3. By Sample

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Test

        16.4.3. By Sample

        16.4.4. By End User

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. Germany New-Born Metabolic Screening Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Test

                16.8.1.2.2. By Sample

                16.8.1.2.3. By End User

        16.8.2. Italy New-Born Metabolic Screening Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Test

                16.8.2.2.2. By Sample

                16.8.2.2.3. By End User

        16.8.3. France New-Born Metabolic Screening Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Test

                16.8.3.2.2. By Sample

                16.8.3.2.3. By End User

        16.8.4. U.K. New-Born Metabolic Screening Market Analysis

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast by Market Taxonomy

                16.8.4.2.1. By Test

                16.8.4.2.2. By Sample

                16.8.4.2.3. By End User

        16.8.5. Spain New-Born Metabolic Screening Market Analysis

            16.8.5.1. Introduction

            16.8.5.2. Market Analysis and Forecast by Market Taxonomy

                16.8.5.2.1. By Test

                16.8.5.2.2. By Sample

                16.8.5.2.3. By End User

        16.8.6. BENELUX New-Born Metabolic Screening Market Analysis

            16.8.6.1. Introduction

            16.8.6.2. Market Analysis and Forecast by Market Taxonomy

                16.8.6.2.1. By Test

                16.8.6.2.2. By Sample

                16.8.6.2.3. By End User

        16.8.7. Russia New-Born Metabolic Screening Market Analysis

            16.8.7.1. Introduction

            16.8.7.2. Market Analysis and Forecast by Market Taxonomy

                16.8.7.2.1. By Test

                16.8.7.2.2. By Sample

                16.8.7.2.3. By End User

17. South Asia New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Indonesia

            17.3.1.3. Thailand

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Test

        17.3.3. By Sample

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Test

        17.4.3. By Sample

        17.4.4. By End User

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. India New-Born Metabolic Screening Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Test

                17.8.1.2.2. By Sample

                17.8.1.2.3. By End User

        17.8.2. Indonesia New-Born Metabolic Screening Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Test

                17.8.2.2.2. By Sample

                17.8.2.2.3. By End User

        17.8.3. Thailand New-Born Metabolic Screening Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Test

                17.8.3.2.2. By Sample

                17.8.3.2.3. By End User

        17.8.4. Malaysia New-Born Metabolic Screening Market Analysis

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast by Market Taxonomy

                17.8.4.2.1. By Test

                17.8.4.2.2. By Sample

                17.8.4.2.3. By End User

18. East Asia New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Test

        18.3.3. By Sample

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Test

        18.4.3. By Sample

        18.4.4. By End User

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. China New-Born Metabolic Screening Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Test

                18.8.1.2.2. By Sample

                18.8.1.2.3. By End User

        18.8.2. Japan New-Born Metabolic Screening Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Test

                18.8.2.2.2. By Sample

                18.8.2.2.3. By End User

        18.8.3. South Korea New-Born Metabolic Screening Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast by Market Taxonomy

                18.8.3.2.1. By Test

                18.8.3.2.2. By Sample

                18.8.3.2.3. By End User

19. Oceania New-Born Metabolic Screening Market 2015-2022 and Forecast 2023-2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Test

        19.3.3. By Sample

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Test

        19.4.3. By Sample

        19.4.4. By End User

    19.5. Market Trends

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis & Forecast

        19.8.1. Australia New-Born Metabolic Screening Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Test

                19.8.1.2.2. By Sample

                19.8.1.2.3. By End User

        19.8.2. New Zealand New-Born Metabolic Screening Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Test

                19.8.2.2.2. By Sample

                19.8.2.2.3. By End User

20. Middle East and Africa (MEA) New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Turkey

            20.3.1.3. South Africa

            20.3.1.4. North Africa

            20.3.1.5. Rest of Middle East and Africa

        20.3.2. By Test

        20.3.3. By Sample

        20.3.4. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Test

        20.4.3. By Sample

        20.4.4. By End User

    20.5. Market Trends

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

    20.8. Country Level Analysis & Forecast

        20.8.1. GCC Countries New-Born Metabolic Screening Market Analysis

            20.8.1.1. Introduction

            20.8.1.2. Market Analysis and Forecast by Market Taxonomy

                20.8.1.2.1. By Test

                20.8.1.2.2. By Sample

                20.8.1.2.3. By End User

        20.8.2. Turkey New-Born Metabolic Screening Market Analysis

            20.8.2.1. Introduction

            20.8.2.2. Market Analysis and Forecast by Market Taxonomy

                20.8.2.2.1. By Test

                20.8.2.2.2. By Sample

                20.8.2.2.3. By End User

        20.8.3. South Africa New-Born Metabolic Screening Market Analysis

            20.8.3.1. Introduction

            20.8.3.2. Market Analysis and Forecast by Market Taxonomy

                20.8.3.2.1. By Test

                20.8.3.2.2. By Sample

                20.8.3.2.3. By End User

        20.8.4. North Africa New-Born Metabolic Screening Market Analysis

            20.8.4.1. Introduction

            20.8.4.2. Market Analysis and Forecast by Market Taxonomy

                20.8.4.2.1. By Test

                20.8.4.2.2. By Sample

                20.8.4.2.3. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of Top Players (%)

    21.3. Market Presence Analysis

        21.3.1. By Regional Footprint of Players

        21.3.2. Product Footprint of Players

        21.3.3. Channel Footprint of Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. PerkinElmer

            22.3.1.1. Overview

            22.3.1.2. Product & Services Portfolio

            22.3.1.3. Key Financials

            22.3.1.4. SWOT Analysis

            22.3.1.5. Key Developments

            22.3.1.6. Sales Footprint

            22.3.1.7. Strategy Overview

                22.3.1.7.1. Marketing Strategy

                22.3.1.7.2. Product Strategy

                22.3.1.7.3. Channel Strategy

        22.3.2. Bio-Rad Laboratories

            22.3.2.1. Overview

            22.3.2.2. Product & Services Portfolio

            22.3.2.3. Key Financials

            22.3.2.4. SWOT Analysis

            22.3.2.5. Key Developments

            22.3.2.6. Sales Footprint

            22.3.2.7. Strategy Overview

                22.3.2.7.1. Marketing Strategy

                22.3.2.7.2. Product Strategy

                22.3.2.7.3. Channel Strategy

        22.3.3. Trivitron Healthcare Private Limited

            22.3.3.1. Overview

            22.3.3.2. Product & Services Portfolio

            22.3.3.3. Key Financials

            22.3.3.4. SWOT Analysis

            22.3.3.5. Key Developments

            22.3.3.6. Sales Footprint

            22.3.3.7. Strategy Overview

                22.3.3.7.1. Marketing Strategy

                22.3.3.7.2. Product Strategy

                22.3.3.7.3. Channel Strategy

        22.3.4. BioMedomics, Inc.

            22.3.4.1. Overview

            22.3.4.2. Product & Services Portfolio

            22.3.4.3. Key Financials

            22.3.4.4. SWOT Analysis

            22.3.4.5. Key Developments

            22.3.4.6. Sales Footprint

            22.3.4.7. Strategy Overview

                22.3.4.7.1. Marketing Strategy

                22.3.4.7.2. Product Strategy

                22.3.4.7.3. Channel Strategy

        22.3.5. Luminex Corporation

            22.3.5.1. Overview

            22.3.5.2. Product & Services Portfolio

            22.3.5.3. Key Financials

            22.3.5.4. SWOT Analysis

            22.3.5.5. Key Developments

            22.3.5.6. Sales Footprint

            22.3.5.7. Strategy Overview

                22.3.5.7.1. Marketing Strategy

                22.3.5.7.2. Product Strategy

                22.3.5.7.3. Channel Strategy

        22.3.6. MP BIOMEDICALS

            22.3.6.1. Overview

            22.3.6.2. Product & Services Portfolio

            22.3.6.3. Key Financials

            22.3.6.4. SWOT Analysis

            22.3.6.5. Key Developments

            22.3.6.6. Sales Footprint

            22.3.6.7. Strategy Overview

                22.3.6.7.1. Marketing Strategy

                22.3.6.7.2. Product Strategy

                22.3.6.7.3. Channel Strategy

        22.3.7. Synergy Medical Systems LLP

            22.3.7.1. Overview

            22.3.7.2. Product & Services Portfolio

            22.3.7.3. Key Financials

            22.3.7.4. SWOT Analysis

            22.3.7.5. Key Developments

            22.3.7.6. Sales Footprint

            22.3.7.7. Strategy Overview

                22.3.7.7.1. Marketing Strategy

                22.3.7.7.2. Product Strategy

                22.3.7.7.3. Channel Strategy

        22.3.8. Agilent Technologies, Inc

            22.3.8.1. Overview

            22.3.8.2. Product & Services Portfolio

            22.3.8.3. Key Financials

            22.3.8.4. SWOT Analysis

            22.3.8.5. Key Developments

            22.3.8.6. Sales Footprint

            22.3.8.7. Strategy Overview

                22.3.8.7.1. Marketing Strategy

                22.3.8.7.2. Product Strategy

                22.3.8.7.3. Channel Strategy

        22.3.9. Thermo Fisher Scientific, Inc

            22.3.9.1. Overview

            22.3.9.2. Product & Services Portfolio

            22.3.9.3. Key Financials

            22.3.9.4. SWOT Analysis

            22.3.9.5. Key Developments

            22.3.9.6. Sales Footprint

            22.3.9.7. Strategy Overview

                22.3.9.7.1. Marketing Strategy

                22.3.9.7.2. Product Strategy

                22.3.9.7.3. Channel Strategy

        22.3.10. Zivak Technologies

            22.3.10.1. Overview

            22.3.10.2. Product & Services Portfolio

            22.3.10.3. Key Financials

            22.3.10.4. SWOT Analysis

            22.3.10.5. Key Developments

            22.3.10.6. Sales Footprint

            22.3.10.7. Strategy Overview

                22.3.10.7.1. Marketing Strategy

                22.3.10.7.2. Product Strategy

                22.3.10.7.3. Channel Strategy

        22.3.11. Covidien Plc

            22.3.11.1. Overview

            22.3.11.2. Product & Services Portfolio

            22.3.11.3. Key Financials

            22.3.11.4. SWOT Analysis

            22.3.11.5. Key Developments

            22.3.11.6. Sales Footprint

            22.3.11.7. Strategy Overview

                22.3.11.7.1. Marketing Strategy

                22.3.11.7.2. Product Strategy

                22.3.11.7.3. Channel Strategy

        22.3.12. AB Sciex LLC

            22.3.12.1. Overview

            22.3.12.2. Product & Services Portfolio

            22.3.12.3. Key Financials

            22.3.12.4. SWOT Analysis

            22.3.12.5. Key Developments

            22.3.12.6. Sales Footprint

            22.3.12.7. Strategy Overview

                22.3.12.7.1. Marketing Strategy

                22.3.12.7.2. Product Strategy

                22.3.12.7.3. Channel Strategy

        22.3.13. Waters Corp.

            22.3.13.1. Overview

            22.3.13.2. Product & Services Portfolio

            22.3.13.3. Key Financials

            22.3.13.4. SWOT Analysis

            22.3.13.5. Key Developments

            22.3.13.6. Sales Footprint

            22.3.13.7. Strategy Overview

                22.3.13.7.1. Marketing Strategy

                22.3.13.7.2. Product Strategy

                22.3.13.7.3. Channel Strategy

        22.3.14. Masimo Corp.

            22.3.14.1. Overview

            22.3.14.2. Product & Services Portfolio

            22.3.14.3. Key Financials

            22.3.14.4. SWOT Analysis

            22.3.14.5. Key Developments

            22.3.14.6. Sales Footprint

            22.3.14.7. Strategy Overview

                22.3.14.7.1. Marketing Strategy

                22.3.14.7.2. Product Strategy

                22.3.14.7.3. Channel Strategy

        22.3.15. Natus Medical Inc.

            22.3.15.1. Overview

            22.3.15.2. Product & Services Portfolio

            22.3.15.3. Key Financials

            22.3.15.4. SWOT Analysis

            22.3.15.5. Key Developments

            22.3.15.6. Sales Footprint

            22.3.15.7. Strategy Overview

                22.3.15.7.1. Marketing Strategy

                22.3.15.7.2. Product Strategy

                22.3.15.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

 

ページTOPに戻る


 

Summary

Global New-Born Metabolic Screening Market: Scope of the Report

The latest publication by Persistence Market Research on the global new-born metabolic screening market evaluates the opportunities and current market landscape, provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for global new-born metabolic screening services and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the global new-born metabolic screening market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the new-born metabolic screening market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the new-born metabolic screening market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the global new-born metabolic screening market offers information divided into four important segments – test, sample, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Test

Galactosemia
Sickle Cell Disease
Cystic Fibrosis
Toxoplasmosis
Phenylketonuria (PKU)
Methylmalonic Acidemia
Maple Syrup Urine Disease (MSUD)
Tyrosinemia
Citrullinemia
Medium Chain Acyl CoA Dehydrogenase (MCAD) Deficiency
Sample

Blood
Urine
End User

Diagnostic Laboratories
Specialty Clinics
Hospitals
Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa
Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for new-born metabolic screening over the coming years?
How will changing trends influence the market?
How has the COVID-19 crisis influenced market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will affect the market?
How can companies in the new-born metabolic screening market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the new-born metabolic screening market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the new-born metabolic screening market are more accurate and reliable.



ページTOPに戻る


Table of Contents

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Development/Innovation Trends

4. Key Success Factors

    4.1. Service Adoption / Usage Analysis

    4.2. New Product Launches

    4.3. Value chain Analysis

    4.4. PESTEL Analysis

    4.5. Porter’s Analysis

    4.6. Key Promotional Strategies, By Key Manufacturers

    4.7. Regulatory Landscape

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure

        5.1.3. Global Metabolic Screening Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increasing End User Facilities

        5.2.2. New-Born Metabolic Screening Penetration Rate

        5.2.3. Key Players Historical Growth

        5.2.4. Newborn Metabolic Screening Adoption Across Regions

        5.2.5. New-Born Metabolic Screening Test Cost

        5.2.6. Technological Advancements

        5.2.7. Regulatory Impositions

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis – Impact Assessment

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Test

        6.1.2. By Sample

        6.1.3. By End User

        6.1.4. By Region

    6.2. 2022 Market Scenario

7. Global New-Born Metabolic Screening Market Demand Volume (Units) Analysis 2015–2022 and Forecast, 2023–2033

    7.1. Historical Market Volume (Units) Analysis, 2015–2022

    7.2. Current and Future Market Volume (Units) Projections, 2023–2033

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global New-Born Metabolic Screening Market Demand Pricing Analysis 2015–2022 and Forecast, 2023–2033

    8.1. Regional Pricing Analysis

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

9. Global New-Born Metabolic Screening Market Demand Value or Size (US$ Mn) Analysis 2015 – 2022 and Forecast, 2023–2033

    9.1. Historical Market Value (US$ Mn) Analysis, 2015 – 2022

    9.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global New-Born Metabolic Screening Market Analysis 2015– 2022 and Forecast 2023–2033, By Test

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test, 2015 – 2022

    10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Test, 2023–2033

        10.3.1. Galactosemia

        10.3.2. Sickle Cell Disease

        10.3.3. Cystic Fibrosis

        10.3.4. Toxoplasmosis

        10.3.5. Phenylketonuria (PKU)

        10.3.6. Methylmalonic Acidemia

        10.3.7. Maple Syrup Urine Disease (MSUD)

        10.3.8. Tyrosinemia

        10.3.9. Citrullinemia

        10.3.10. Medium Chain Acyl CoA Dehydrogenase (MCAD) Deficiency

    10.4. Market Attractiveness Analysis By Test

11. Global New-Born Metabolic Screening Market Analysis 2015– 2022 and Forecast 2023–2033, By Sample

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) By Sample, 2015 – 2022

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample, 2023–2033

        11.3.1. Blood

        11.3.2. Urine

    11.4. Market Attractiveness Analysis By Sample

12. Global New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033, By End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) By End User, 2015 – 2022

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033

        12.3.1. Diagnostic Laboratories

        12.3.2. Specialty Clinics

        12.3.3. Hospitals

    12.4. Market Attractiveness Analysis By End User

13. Global New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033, By Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Region, 2015 – 2022

    13.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Region, 2023–2033

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. South Asia

        13.3.5. East Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Trend Analysis by Market Taxonomy, 2015 – 2022

    14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        14.3.1. By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Test

        14.3.3. By Sample

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Test

        14.4.3. By Sample

        14.4.4. By End User

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. U.S. New-Born Metabolic Screening Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Test

                14.8.1.2.2. By Sample

                14.8.1.2.3. By End User

        14.8.2. Canada New-Born Metabolic Screening Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Test

                14.8.2.2.2. By Sample

                14.8.2.2.3. By End User

15. Latin America New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        15.3.1.  By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Test

        15.3.3. By Sample

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Test

        15.4.3. By Sample

        15.4.4. By End User

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. Brazil New-Born Metabolic Screening Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Test

                15.8.1.2.2. By Sample

                15.8.1.2.3. By End User

        15.8.2. Mexico New-Born Metabolic Screening Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Test

                15.8.2.2.2. By Sample

                15.8.2.2.3. By End User

        15.8.3. Argentina New-Born Metabolic Screening Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Test

                15.8.3.2.2. By Sample

                15.8.3.2.3. By End User

16. Europe New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

        16.3.2. By Test

        16.3.3. By Sample

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Test

        16.4.3. By Sample

        16.4.4. By End User

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. Germany New-Born Metabolic Screening Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Test

                16.8.1.2.2. By Sample

                16.8.1.2.3. By End User

        16.8.2. Italy New-Born Metabolic Screening Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Test

                16.8.2.2.2. By Sample

                16.8.2.2.3. By End User

        16.8.3. France New-Born Metabolic Screening Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Test

                16.8.3.2.2. By Sample

                16.8.3.2.3. By End User

        16.8.4. U.K. New-Born Metabolic Screening Market Analysis

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast by Market Taxonomy

                16.8.4.2.1. By Test

                16.8.4.2.2. By Sample

                16.8.4.2.3. By End User

        16.8.5. Spain New-Born Metabolic Screening Market Analysis

            16.8.5.1. Introduction

            16.8.5.2. Market Analysis and Forecast by Market Taxonomy

                16.8.5.2.1. By Test

                16.8.5.2.2. By Sample

                16.8.5.2.3. By End User

        16.8.6. BENELUX New-Born Metabolic Screening Market Analysis

            16.8.6.1. Introduction

            16.8.6.2. Market Analysis and Forecast by Market Taxonomy

                16.8.6.2.1. By Test

                16.8.6.2.2. By Sample

                16.8.6.2.3. By End User

        16.8.7. Russia New-Born Metabolic Screening Market Analysis

            16.8.7.1. Introduction

            16.8.7.2. Market Analysis and Forecast by Market Taxonomy

                16.8.7.2.1. By Test

                16.8.7.2.2. By Sample

                16.8.7.2.3. By End User

17. South Asia New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Indonesia

            17.3.1.3. Thailand

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Test

        17.3.3. By Sample

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Test

        17.4.3. By Sample

        17.4.4. By End User

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. India New-Born Metabolic Screening Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Test

                17.8.1.2.2. By Sample

                17.8.1.2.3. By End User

        17.8.2. Indonesia New-Born Metabolic Screening Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Test

                17.8.2.2.2. By Sample

                17.8.2.2.3. By End User

        17.8.3. Thailand New-Born Metabolic Screening Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Test

                17.8.3.2.2. By Sample

                17.8.3.2.3. By End User

        17.8.4. Malaysia New-Born Metabolic Screening Market Analysis

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast by Market Taxonomy

                17.8.4.2.1. By Test

                17.8.4.2.2. By Sample

                17.8.4.2.3. By End User

18. East Asia New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Test

        18.3.3. By Sample

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Test

        18.4.3. By Sample

        18.4.4. By End User

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. China New-Born Metabolic Screening Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Test

                18.8.1.2.2. By Sample

                18.8.1.2.3. By End User

        18.8.2. Japan New-Born Metabolic Screening Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Test

                18.8.2.2.2. By Sample

                18.8.2.2.3. By End User

        18.8.3. South Korea New-Born Metabolic Screening Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast by Market Taxonomy

                18.8.3.2.1. By Test

                18.8.3.2.2. By Sample

                18.8.3.2.3. By End User

19. Oceania New-Born Metabolic Screening Market 2015-2022 and Forecast 2023-2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Test

        19.3.3. By Sample

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Test

        19.4.3. By Sample

        19.4.4. By End User

    19.5. Market Trends

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis & Forecast

        19.8.1. Australia New-Born Metabolic Screening Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Test

                19.8.1.2.2. By Sample

                19.8.1.2.3. By End User

        19.8.2. New Zealand New-Born Metabolic Screening Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Test

                19.8.2.2.2. By Sample

                19.8.2.2.3. By End User

20. Middle East and Africa (MEA) New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022

    20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Turkey

            20.3.1.3. South Africa

            20.3.1.4. North Africa

            20.3.1.5. Rest of Middle East and Africa

        20.3.2. By Test

        20.3.3. By Sample

        20.3.4. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Test

        20.4.3. By Sample

        20.4.4. By End User

    20.5. Market Trends

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

    20.8. Country Level Analysis & Forecast

        20.8.1. GCC Countries New-Born Metabolic Screening Market Analysis

            20.8.1.1. Introduction

            20.8.1.2. Market Analysis and Forecast by Market Taxonomy

                20.8.1.2.1. By Test

                20.8.1.2.2. By Sample

                20.8.1.2.3. By End User

        20.8.2. Turkey New-Born Metabolic Screening Market Analysis

            20.8.2.1. Introduction

            20.8.2.2. Market Analysis and Forecast by Market Taxonomy

                20.8.2.2.1. By Test

                20.8.2.2.2. By Sample

                20.8.2.2.3. By End User

        20.8.3. South Africa New-Born Metabolic Screening Market Analysis

            20.8.3.1. Introduction

            20.8.3.2. Market Analysis and Forecast by Market Taxonomy

                20.8.3.2.1. By Test

                20.8.3.2.2. By Sample

                20.8.3.2.3. By End User

        20.8.4. North Africa New-Born Metabolic Screening Market Analysis

            20.8.4.1. Introduction

            20.8.4.2. Market Analysis and Forecast by Market Taxonomy

                20.8.4.2.1. By Test

                20.8.4.2.2. By Sample

                20.8.4.2.3. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of Top Players (%)

    21.3. Market Presence Analysis

        21.3.1. By Regional Footprint of Players

        21.3.2. Product Footprint of Players

        21.3.3. Channel Footprint of Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. PerkinElmer

            22.3.1.1. Overview

            22.3.1.2. Product & Services Portfolio

            22.3.1.3. Key Financials

            22.3.1.4. SWOT Analysis

            22.3.1.5. Key Developments

            22.3.1.6. Sales Footprint

            22.3.1.7. Strategy Overview

                22.3.1.7.1. Marketing Strategy

                22.3.1.7.2. Product Strategy

                22.3.1.7.3. Channel Strategy

        22.3.2. Bio-Rad Laboratories

            22.3.2.1. Overview

            22.3.2.2. Product & Services Portfolio

            22.3.2.3. Key Financials

            22.3.2.4. SWOT Analysis

            22.3.2.5. Key Developments

            22.3.2.6. Sales Footprint

            22.3.2.7. Strategy Overview

                22.3.2.7.1. Marketing Strategy

                22.3.2.7.2. Product Strategy

                22.3.2.7.3. Channel Strategy

        22.3.3. Trivitron Healthcare Private Limited

            22.3.3.1. Overview

            22.3.3.2. Product & Services Portfolio

            22.3.3.3. Key Financials

            22.3.3.4. SWOT Analysis

            22.3.3.5. Key Developments

            22.3.3.6. Sales Footprint

            22.3.3.7. Strategy Overview

                22.3.3.7.1. Marketing Strategy

                22.3.3.7.2. Product Strategy

                22.3.3.7.3. Channel Strategy

        22.3.4. BioMedomics, Inc.

            22.3.4.1. Overview

            22.3.4.2. Product & Services Portfolio

            22.3.4.3. Key Financials

            22.3.4.4. SWOT Analysis

            22.3.4.5. Key Developments

            22.3.4.6. Sales Footprint

            22.3.4.7. Strategy Overview

                22.3.4.7.1. Marketing Strategy

                22.3.4.7.2. Product Strategy

                22.3.4.7.3. Channel Strategy

        22.3.5. Luminex Corporation

            22.3.5.1. Overview

            22.3.5.2. Product & Services Portfolio

            22.3.5.3. Key Financials

            22.3.5.4. SWOT Analysis

            22.3.5.5. Key Developments

            22.3.5.6. Sales Footprint

            22.3.5.7. Strategy Overview

                22.3.5.7.1. Marketing Strategy

                22.3.5.7.2. Product Strategy

                22.3.5.7.3. Channel Strategy

        22.3.6. MP BIOMEDICALS

            22.3.6.1. Overview

            22.3.6.2. Product & Services Portfolio

            22.3.6.3. Key Financials

            22.3.6.4. SWOT Analysis

            22.3.6.5. Key Developments

            22.3.6.6. Sales Footprint

            22.3.6.7. Strategy Overview

                22.3.6.7.1. Marketing Strategy

                22.3.6.7.2. Product Strategy

                22.3.6.7.3. Channel Strategy

        22.3.7. Synergy Medical Systems LLP

            22.3.7.1. Overview

            22.3.7.2. Product & Services Portfolio

            22.3.7.3. Key Financials

            22.3.7.4. SWOT Analysis

            22.3.7.5. Key Developments

            22.3.7.6. Sales Footprint

            22.3.7.7. Strategy Overview

                22.3.7.7.1. Marketing Strategy

                22.3.7.7.2. Product Strategy

                22.3.7.7.3. Channel Strategy

        22.3.8. Agilent Technologies, Inc

            22.3.8.1. Overview

            22.3.8.2. Product & Services Portfolio

            22.3.8.3. Key Financials

            22.3.8.4. SWOT Analysis

            22.3.8.5. Key Developments

            22.3.8.6. Sales Footprint

            22.3.8.7. Strategy Overview

                22.3.8.7.1. Marketing Strategy

                22.3.8.7.2. Product Strategy

                22.3.8.7.3. Channel Strategy

        22.3.9. Thermo Fisher Scientific, Inc

            22.3.9.1. Overview

            22.3.9.2. Product & Services Portfolio

            22.3.9.3. Key Financials

            22.3.9.4. SWOT Analysis

            22.3.9.5. Key Developments

            22.3.9.6. Sales Footprint

            22.3.9.7. Strategy Overview

                22.3.9.7.1. Marketing Strategy

                22.3.9.7.2. Product Strategy

                22.3.9.7.3. Channel Strategy

        22.3.10. Zivak Technologies

            22.3.10.1. Overview

            22.3.10.2. Product & Services Portfolio

            22.3.10.3. Key Financials

            22.3.10.4. SWOT Analysis

            22.3.10.5. Key Developments

            22.3.10.6. Sales Footprint

            22.3.10.7. Strategy Overview

                22.3.10.7.1. Marketing Strategy

                22.3.10.7.2. Product Strategy

                22.3.10.7.3. Channel Strategy

        22.3.11. Covidien Plc

            22.3.11.1. Overview

            22.3.11.2. Product & Services Portfolio

            22.3.11.3. Key Financials

            22.3.11.4. SWOT Analysis

            22.3.11.5. Key Developments

            22.3.11.6. Sales Footprint

            22.3.11.7. Strategy Overview

                22.3.11.7.1. Marketing Strategy

                22.3.11.7.2. Product Strategy

                22.3.11.7.3. Channel Strategy

        22.3.12. AB Sciex LLC

            22.3.12.1. Overview

            22.3.12.2. Product & Services Portfolio

            22.3.12.3. Key Financials

            22.3.12.4. SWOT Analysis

            22.3.12.5. Key Developments

            22.3.12.6. Sales Footprint

            22.3.12.7. Strategy Overview

                22.3.12.7.1. Marketing Strategy

                22.3.12.7.2. Product Strategy

                22.3.12.7.3. Channel Strategy

        22.3.13. Waters Corp.

            22.3.13.1. Overview

            22.3.13.2. Product & Services Portfolio

            22.3.13.3. Key Financials

            22.3.13.4. SWOT Analysis

            22.3.13.5. Key Developments

            22.3.13.6. Sales Footprint

            22.3.13.7. Strategy Overview

                22.3.13.7.1. Marketing Strategy

                22.3.13.7.2. Product Strategy

                22.3.13.7.3. Channel Strategy

        22.3.14. Masimo Corp.

            22.3.14.1. Overview

            22.3.14.2. Product & Services Portfolio

            22.3.14.3. Key Financials

            22.3.14.4. SWOT Analysis

            22.3.14.5. Key Developments

            22.3.14.6. Sales Footprint

            22.3.14.7. Strategy Overview

                22.3.14.7.1. Marketing Strategy

                22.3.14.7.2. Product Strategy

                22.3.14.7.3. Channel Strategy

        22.3.15. Natus Medical Inc.

            22.3.15.1. Overview

            22.3.15.2. Product & Services Portfolio

            22.3.15.3. Key Financials

            22.3.15.4. SWOT Analysis

            22.3.15.5. Key Developments

            22.3.15.6. Sales Footprint

            22.3.15.7. Strategy Overview

                22.3.15.7.1. Marketing Strategy

                22.3.15.7.2. Product Strategy

                22.3.15.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Persistence Market Research社はどのような調査会社ですか?


パーシスタンスマーケットリサーチ(Persistence Market Research/PMR)は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る